Beijing SL Pharmaceutical financials at a glance

Year Year 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2004 2021 2022 2023 2024
Rev. Revenue
¥118.56M ¥146.12M ¥237.53M ¥358.00M ¥390.02M ¥457.84M ¥622.77M ¥1.01B ¥1.16B ¥1.24B ¥1.16B ¥1.01B ¥1.24B ¥2.17B ¥2.03B ¥1.11B ¥93.05M ¥1.21B ¥1.05B ¥1.02B ¥0.00M
GM % Gross Margin %
61.28% 63.22% 65.64% 86.30% 82.83% 76.68% 75.39% 66.66% 67.16% 69.89% 65.86% 65.00% 70.52% 79.22% 79.34% 84.93% 65.12% 84.89% 85.05% 81.56% 0.00%
OM Operating Margin
28.25% 32.59% 39.75% 65.17% 61.54% 56.26% 58.44% 51.35% 51.94% 57.31% 49.73% 44.98% 30.03% 30.52% 22.63% 13.47% 36.27% 17.48% 13.68% 24.56% 0.00%
EPS Earnings Per Share
¥0.03 ¥0.03 ¥0.13 ¥0.22 ¥0.26 ¥0.24 ¥0.32 ¥0.45 ¥0.53 ¥0.62 ¥0.51 ¥0.41 ¥0.33 ¥0.54 ¥0.23 ¥0.00
Div. Dividends
¥0.00 ¥0.00 ¥0.00 ¥0.05 ¥0.05 ¥0.06 ¥0.07 ¥0.09 ¥0.09 ¥0.13 ¥0.13 ¥0.13 ¥0.33 ¥0.20 ¥0.20 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.15 ¥0.00
PR % Payout Ratio %
0 0 0 22.73% 19.23% 25.00% 21.88% 20.00% 16.98% 20.97% 25.49% 31.71% 100.00% 37.04% 0 0 0 0 0 65.22% 0
Sha. Shares
1006.02m 1006.02m 1006.02m 1006.02m 1010.01m 1020.11m 1027.89m 1027.89m 1027.89m 1027.89m 1027.35m 1027.35m 1027.35m 1027.35m 1027.35m 1027.35m 0m 1027.35m 1027.35m 0m 1027.35m
OCF Operating Cash Flow
¥47.48M ¥60.78M ¥88.36M ¥194.32M ¥174.41M ¥238.13M ¥228.59M ¥398.60M ¥347.41M ¥465.00M ¥504.87M ¥396.86M ¥383.01M ¥485.17M ¥665.83M ¥415.84M ¥0.00M ¥464.63M ¥389.82M ¥460.20M ¥0.00M
FCF Free Cash Flow
¥-33.76M ¥-4.17M ¥61.75M ¥170.71M ¥143.95M ¥195.09M ¥155.54M ¥150.71M ¥237.93M ¥314.24M ¥375.19M ¥232.65M ¥153.36M ¥257.80M ¥393.05M ¥159.89M ¥0.00M ¥227.72M ¥226.33M ¥241.84M ¥0.00M
FCFS Free Cash Flow Per Share
¥-0.03 ¥-0.00 ¥0.06 ¥0.17 ¥0.14 ¥0.19 ¥0.15 ¥0.15 ¥0.23 ¥0.31 ¥0.37 ¥0.23 ¥0.15 ¥0.25 ¥0.38 ¥0.16 ¥0.00 ¥0.22 ¥0.22 ¥0.24 ¥0.00